Cargando…
Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
The non-pathogenic parvovirus, adeno-associated virus (AAV), is an efficient vector for transgene expression in vivo and shows promise for treatment of brain disorders in clinical trials. Currently, there are more than 100 AAV serotypes identified that differ in the binding capacity of capsid protei...
Autores principales: | Hammond, Sean L., Leek, Ashley N., Richman, Evan H., Tjalkens, Ronald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731760/ https://www.ncbi.nlm.nih.gov/pubmed/29244806 http://dx.doi.org/10.1371/journal.pone.0188830 |
Ejemplares similares
-
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice
por: Hana, Sam, et al.
Publicado: (2021) -
Cellular and Tissue Selectivity of AAV Serotypes for Gene Delivery to Chondrocytes and Cartilage
por: Yoon, Dong Suk, et al.
Publicado: (2021) -
Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013) -
Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice
por: Torregrosa, Tess, et al.
Publicado: (2021) -
Lipid nanoparticle delivery limits antisense oligonucleotide activity and cellular distribution in the brain after intracerebroventricular injection
por: Byrnes, Amy E., et al.
Publicado: (2023)